Global edition
Region
NewsCase StudiesWebcastsInterviewsEventsPodcastsMagazine
Sign inSubscribe
Follow Pharma Now@pharmanow.live
Editions & local coverage
United StatesUnited KingdomGermanyFranceItalyIndiaSwitzerlandSingapore

A global knowledge and leadership platform for pharma. We turn complexity into clarity professionals can act on.

Get the Pharma Now app

Read offline, save stories and never miss an edition.

Get it onGoogle PlayDownload on theApp Store
Verticals
  • Leadership
  • AI in Pharma
  • Manufacturing
  • Marketing
  • HR in Pharma
  • Microbiology & CCS
  • Regulatory Landscape
Formats
  • News & Analysis
  • Interviews
  • Case Studies
  • Webcasts
  • Podcasts
  • Events
  • Magazine
Knowledge Hub
  • Knowledge Hub
  • Research Papers
  • Buyer’s Guides
  • Companies
  • Newsletter Archive
  • Glossary
Company
  • Advisory Board
  • Contributors
  • Write for Us
  • Submit a PR
  • Contact
  • Advertise
Account
  • Subscribe
  • Sign in
  • My Account
  • Partner with us
Frequently asked

Pharma Now is a leading monthly B2B magazine focused on delivering in-depth content related to the pharmaceutical and biopharma sectors. It covers the latest trends, technological innovations, leadership insights, market developments, and interviews with industry experts.

Pharma Now provides comprehensive coverage, including: - Industry news and updates - Interviews with global pharma leaders - Market insights and trends - Innovations in AI, manufacturing, and pharma operations - Case studies, thought leadership articles, and regulatory updates

Pharma Now caters to a wide range of professionals within the pharmaceutical industry, including C-level executives, R&D professionals, quality managers, regulatory affairs specialists, and business leaders looking to stay informed about global trends and innovations.

You can subscribe to Pharma Now by visiting the Pharma Now website and choosing between print and digital editions.

Yes, Pharma Now welcomes contributions from industry experts. Contributors can submit articles, thought leadership pieces, and case studies. You can register on the contributors' page to submit content and gain recognition for your insights.

Pharma Now offers multiple advertising packages tailored to help companies promote their products, services, and innovations. From full-page ads to special event coverage, advertisers can reach a targeted audience of pharma professionals. For details, visit the Advertise With Us section on the website.

Copyright © 2026 Tantragyan Technologies Pvt Ltd. All Rights Reserved.
Privacy PolicyTerms of UseContact UsAdvertise
Companies/WuXi Biologics
WuXi Biologics

WuXi Biologics

Contract Development & Manufacturing (CDMO/CMO)
APIs & Intermediates
Visit website ↗Contact
LinkedIn

About WuXi Biologics

WuXi Biologics is a leading global Contract Research, Development and Manufacturing Organization (CRDMO), providing comprehensive, integrated solutions for the discovery, development, and production of biologics. With a presence in key international markets and cutting-edge facilities, WuXi Biologics empowers pharmaceutical and biotech partners to bring biologics to market faster, cost-effectively, and with regulatory confidence.

From early-stage discovery and cell line development to clinical and commercial manufacturing, WuXi Biologics offers flexible, scalable, and high-quality biologics services tailored to each project. The company emphasizes innovation, digital transformation, and sustainability, supporting a global client base across biologics, biosimilars, and advanced therapeutics.

Trusted for scientific expertise and operational excellence, WuXi Biologics continues to transform the biologics development landscape, accelerating timelines and enabling global access to life-saving therapies.

Company details
IndustryContract Development & Manufacturing (CDMO/CMO)
CategoryAPIs & Intermediates
Head office108 meiliang road, mashan, binhu district, wuxi, jiangsu - 214092,
ContactSusan Scott
Phone+86 510 8183 1205
Emailsusan.scott@wuxibiologics.com
Websitewww.wuxibiologics.com
The signal
The week in pharma, distilled

One considered email — the stories, moves and numbers that matter, every Friday.